During the last session, Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares were 5.92 million, with the beta value of the company hitting 2.15. At
In the last trading session, 13.77 million shares of the Pacific Biosciences of California Inc (NASDAQ:PACB) were traded, and its beta was 2.15. Most recently
In the last trading session, 11.66 million Pacific Biosciences of California Inc (NASDAQ:PACB) shares changed hands as the company’s beta touched 2.16. With the company’s
In last trading session, Pacific Biosciences of California Inc (NASDAQ:PACB) saw 11.83 million shares changing hands with its beta currently measuring 2.13. Company’s recent per
Pacific Biosciences of California Inc (NASDAQ:PACB) has a beta value of -69.02% and has seen 8.77 shares traded in the last trading session. The company,
In the last trading session, 9.67 million shares of the Pacific Biosciences of California Inc (NASDAQ:PACB) were traded, and its beta was 2.13. Most recently
Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares stood at 6.03 million during the last session, with the company’s beta value hitting 2.11. At the
In the last trading session, 11.2 million Pacific Biosciences of California Inc (NASDAQ:PACB) shares changed hands as the company’s beta touched 2.10. With the company’s
In last trading session, Pacific Biosciences of California Inc (NASDAQ:PACB) saw 4.82 million shares changing hands with its beta currently measuring 2.10. Company’s recent per
Pacific Biosciences of California Inc (NASDAQ:PACB) has a beta value of 2.12 and has seen 11.52 million shares traded in the last trading session. The
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne